clinical trial · NCT04176224
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
Japanese Patients With ALSMT-1186
brief summary
To evaluate the pharmacokinetics of single doses of edaravone oral suspension in Patients with Amyotrophic Lateral Sclerosis
started
Apr 17, 2019
primary completion
Sep 4, 2019
completion
Sep 4, 2019
last updated
Jul 15, 2026
official title
Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol